Currently, perimenopause affects millions of women in their 30s, 40s, and early 50s — yet as many as half go undiagnosed and untreated. Because the transition begins gradually, often up to 10 years before the final menstrual period, many women mistake the early symptoms for stress, depression, thyroid problems, or simply getting older. And while some women sail through perimenopause with minimal disruption, many experience symptoms that significantly affect their quality of life, relationships, and professional performance — without ever receiving a diagnosis or treatment.
Perimenopause can begin up to 10 years before menopause, often with subtle symptoms that are easy to overlook or attribute to other causes.
Answer 20 simple yes/no questions to find out whether your symptoms may be related to perimenopause and what steps you can take.
Select the answer that best applies to you.
Perimenopause Self-Assessment — HRT.org
Perimenopause — literally "around menopause" — is the transitional phase that precedes menopause, during which the ovaries gradually produce less oestrogen and progesterone. It typically begins in a woman's 40s (though it can start in the late 30s) and lasts anywhere from a few months to more than 10 years. Perimenopause ends, and menopause begins, when a woman has gone 12 consecutive months without a menstrual period. Unlike menopause itself, perimenopause is characterised by fluctuating — rather than consistently low — hormone levels. This hormonal volatility is responsible for many of the most disruptive symptoms women experience, including irregular periods, mood instability, and hot flashes.
Oestrogen is the primary female sex hormone, produced mainly in the ovaries and playing a fundamental role in regulating the menstrual cycle, bone density, cardiovascular health, brain function, skin elasticity, vaginal health, and mood. During perimenopause, oestrogen production becomes irregular and eventually declines — affecting virtually every major organ system in the body. Progesterone, which works in balance with oestrogen throughout the cycle, also declines — often falling before oestrogen does, contributing to symptoms of oestrogen dominance in the early perimenopausal transition.
- Irregular, heavier, or lighter periods than usual
- Hot flashes and night sweats
- Sleep disturbance or insomnia
- Mood swings, irritability, and anger
- Anxiety or increased worry
- Depression or low mood
- Fatigue and lack of energy
- Decreased concentration, alertness, or memory loss (brain fog)
- Vaginal dryness or pain
- Urinary changes or increased urgency
- Decreased sex drive (libido)
- Water retention, bloating, and weight gain around the middle
- Breast tenderness
- Headaches or migraines — particularly premenstrually
- Thinning hair on the scalp
- Skin changes — dryness, acne, or increased sensitivity
Yes, you can test your hormone levels at home using a reliable at-home female hormone test kit. Testing oestradiol, progesterone, FSH, LH, and testosterone during perimenopause helps map where you are in the transition and guides treatment decisions. Because hormone levels fluctuate considerably during perimenopause, testing at the same point in your cycle on two separate occasions provides the most accurate picture. You can also use our quiz above as a validated screening tool before deciding whether to order a full hormone panel.
- Early perimenopause — Cycles remain regular but begin to show subtle changes in length or flow. Progesterone is the first hormone to decline, often producing premenstrual mood changes, breast tenderness, and sleep disruption before oestrogen levels fall significantly.
- Late perimenopause — Cycles become irregular, with gaps of more than 60 days between periods. Oestrogen levels begin to fluctuate widely, causing hot flashes, night sweats, and more pronounced mood changes. This stage typically lasts 1–3 years.
- Final menstrual period — The last period, which can only be confirmed in retrospect after 12 consecutive months without bleeding.
- Postmenopause — The phase following the final menstrual period, when oestrogen and progesterone production from the ovaries has permanently ceased.
The following blood tests are available to assess hormonal status during perimenopause:
- Oestradiol (E2) — levels fluctuate widely during perimenopause; multiple measurements provide a clearer picture
- Progesterone — taken on day 21 of the cycle to confirm ovulation and assess luteal phase adequacy
- FSH (Follicle-Stimulating Hormone) — begins to rise as ovarian function declines
- LH (Luteinising Hormone) — elevated alongside FSH in ovarian insufficiency
- Testosterone (total and free) — declines through the perimenopausal transition; contributes to reduced libido, energy, and mood
- SHBG (Sex Hormone-Binding Globulin) — affects the amount of free, active hormone available
- TSH, Free T3, Free T4 — thyroid disorders are common in this age group and closely mimic perimenopausal symptoms
- Cortisol and adrenal profile — adrenal stress compounds hormonal symptoms significantly
Oestradiol Test—This test measures the primary active form of oestrogen in the blood. During perimenopause, oestradiol levels fluctuate widely — sometimes spiking higher than normal before declining. Testing on different days of the cycle helps map the pattern of hormonal change.
Progesterone Test—Taken on day 21 of the cycle (or 7 days after ovulation), this test confirms whether ovulation occurred and assesses the adequacy of the luteal phase. Declining progesterone is one of the earliest hormonal changes in perimenopause and is responsible for many early symptoms.
FSH Test—As the ovaries become less responsive, the pituitary gland releases more FSH in an attempt to stimulate them. Rising FSH alongside fluctuating oestradiol is characteristic of perimenopause.
Testosterone Test—Testosterone declines gradually through the 40s and contributes significantly to reduced libido, fatigue, and motivation during perimenopause. Low-dose testosterone therapy alongside oestrogen has strong supporting evidence.
Oestradiol Test—Fluctuating or erratic oestradiol levels across multiple tests confirm the perimenopausal transition. A consistently falling oestradiol alongside rising FSH indicates progression toward menopause.
Progesterone Test—A low day-21 progesterone (below 16 nmol/L) indicates anovulation or poor luteal phase function, both common in perimenopause and responsible for irregular cycles, mood changes, and heavy bleeding.
FSH Test—Rising FSH (above 10 IU/L and trending upward) indicates declining ovarian reserve and confirms entry into perimenopause. You can also assess this using our Comprehensive Female Hormone Home Test Kit.
Testosterone Test—Low testosterone contributes to reduced libido, low mood, and fatigue. Testosterone therapy alongside oestrogen can meaningfully improve these symptoms in perimenopausal women.
Common Causes of Perimenopausal Symptoms
- Natural age-related decline in ovarian oestrogen and progesterone production
- Early or accelerated ovarian ageing
- Autoimmune conditions affecting ovarian function
- Chronic stress and elevated cortisol — which suppresses progesterone production and amplifies oestrogen withdrawal symptoms
- Thyroid dysfunction — commonly co-occurs and worsens perimenopausal symptoms
- Nutritional deficiencies (magnesium, vitamin D, B vitamins, omega-3 fatty acids)
- Poor sleep — both a symptom and an amplifier of hormonal dysregulation
- Smoking — associated with earlier onset of perimenopause
Treatment for perimenopause may include:
- Bioidentical progesterone — micronised progesterone is often the first treatment used in perimenopause to address progesterone deficiency, improving sleep, mood, and cycle regularity
- Oestradiol — low-dose transdermal oestradiol for women with significant oestrogen-related symptoms such as hot flashes, night sweats, and vaginal dryness
- Testosterone — low-dose topical testosterone for reduced libido, fatigue, and mood changes
- Combined HRT — oestradiol and micronised progesterone used together once oestrogen deficiency symptoms become prominent
- Mirena IUS — provides progestogenic endometrial protection while allowing systemic oestradiol to be used transdermally
- SSRIs and SNRIs — for mood and vasomotor symptoms in women who prefer not to use hormonal therapy
Natural support may also include magnesium glycinate (300–400mg before bed) for sleep and mood, vitamin B6 for premenstrual symptoms, omega-3 fatty acids, reducing caffeine and alcohol particularly in the second half of the cycle, and regular aerobic exercise. Mindfulness and stress reduction are particularly important given the role of cortisol in amplifying hormonal symptoms during this transition.
Based on your perimenopause assessment and symptoms, you may be experiencing the perimenopausal transition.
See a healthcare practitioner to discuss your symptoms and possible testing, or order tests on your own and share results with your doctor.
References
1Santoro N, et al. "Perimenopause: From Research to Practice." J Womens Health. 2016;25(4):332–339.
2Prior JC. "Progesterone for Symptomatic Perimenopause Treatment." J Obstet Gynaecol Can. 2011;33(12):1249–1256.
3"Menopause: diagnosis and management." NICE Guideline NG23. National Institute for Health and Care Excellence, 2015 (updated 2019).
A deficiency or fluctuation of oestrogen and progesterone during perimenopause can affect virtually all body functions. The severity of symptoms ranges from mild and barely noticeable to severely debilitating — disrupting sleep, mood, relationships, and professional performance. Because symptoms develop gradually and are often attributed to stress or ageing, many women go years without the correct diagnosis or treatment.
Self-assessment Questionnaire
Because many symptoms of perimenopause are similar to those of thyroid disorders, depression, adrenal fatigue, and other conditions, they can easily be confused or misinterpreted. The key distinguishing features of perimenopause are the relationship of symptoms to the menstrual cycle, the gradual onset in the mid-to-late 40s, and the characteristic pattern of sleep disruption, mood instability, and cycle irregularity appearing together.
We strongly suggest that you contact your healthcare provider if you have any concerns that you may be experiencing perimenopause. The self-assessment above should not be substituted for hormone testing and clinical evaluation by your provider.
A perimenopause assessment is typically done by combining a clinical symptom evaluation — such as the quiz on this page — with blood tests measuring oestradiol, progesterone (day 21), FSH, LH, and testosterone. Because hormone levels fluctuate widely during perimenopause, testing on two separate occasions gives a more accurate picture. Thyroid function should always be assessed at the same time, as thyroid disorders are common in this age group and produce overlapping symptoms.
Yes, most home hormone tests are accurate when used correctly and processed by certified laboratories. Blood spot tests for oestradiol, progesterone, FSH, and testosterone provide results clinically comparable to venous blood draws and are a convenient and private way to begin hormonal assessment.
Online perimenopause assessments using validated symptom questionnaires and at-home hormone test kits are effective and increasingly used in clinical and functional medicine practice. They provide a practical first step in identifying hormonal changes and determining whether further investigation or treatment is warranted.
Yes, physical signs of perimenopause include changes in menstrual cycle length and flow, hot flashes, night sweats, vaginal dryness, skin thinning, thinning scalp hair, increased facial hair, weight redistribution to the abdomen, and breast tenderness. Joint stiffness and palpitations are also commonly reported but frequently overlooked as perimenopausal symptoms.
